rs2245649

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000208.4(INSR):​c.1862-4A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0909 in 1,602,380 control chromosomes in the GnomAD database, including 9,322 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 1700 hom., cov: 30)
Exomes 𝑓: 0.087 ( 7622 hom. )

Consequence

INSR
NM_000208.4 splice_region, intron

Scores

2
Splicing: ADA: 0.0001008
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -3.40

Publications

19 publications found
Variant links:
Genes affected
INSR (HGNC:6091): (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
INSR Gene-Disease associations (from GenCC):
  • insulin-resistance syndrome type A
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
  • Donohue syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • hyperinsulinism due to INSR deficiency
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
  • Rabson-Mendenhall syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 19-7163203-T-C is Benign according to our data. Variant chr19-7163203-T-C is described in ClinVar as Benign. ClinVar VariationId is 330469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.241 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000208.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INSR
NM_000208.4
MANE Select
c.1862-4A>G
splice_region intron
N/ANP_000199.2
INSR
NM_001079817.3
c.1862-4A>G
splice_region intron
N/ANP_001073285.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INSR
ENST00000302850.10
TSL:1 MANE Select
c.1862-4A>G
splice_region intron
N/AENSP00000303830.4
INSR
ENST00000341500.9
TSL:1
c.1862-4A>G
splice_region intron
N/AENSP00000342838.4
INSR
ENST00000598216.1
TSL:1
n.1837-4A>G
splice_region intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.126
AC:
19104
AN:
151808
Hom.:
1693
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.245
Gnomad AMI
AF:
0.157
Gnomad AMR
AF:
0.0829
Gnomad ASJ
AF:
0.0461
Gnomad EAS
AF:
0.0284
Gnomad SAS
AF:
0.244
Gnomad FIN
AF:
0.0387
Gnomad MID
AF:
0.0918
Gnomad NFE
AF:
0.0796
Gnomad OTH
AF:
0.118
GnomAD2 exomes
AF:
0.0983
AC:
24702
AN:
251252
AF XY:
0.104
show subpopulations
Gnomad AFR exome
AF:
0.243
Gnomad AMR exome
AF:
0.0601
Gnomad ASJ exome
AF:
0.0490
Gnomad EAS exome
AF:
0.0259
Gnomad FIN exome
AF:
0.0449
Gnomad NFE exome
AF:
0.0774
Gnomad OTH exome
AF:
0.0917
GnomAD4 exome
AF:
0.0873
AC:
126575
AN:
1450454
Hom.:
7622
Cov.:
31
AF XY:
0.0915
AC XY:
66083
AN XY:
722058
show subpopulations
African (AFR)
AF:
0.242
AC:
7956
AN:
32884
American (AMR)
AF:
0.0633
AC:
2831
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.0474
AC:
1236
AN:
26080
East Asian (EAS)
AF:
0.0302
AC:
1198
AN:
39652
South Asian (SAS)
AF:
0.233
AC:
19944
AN:
85758
European-Finnish (FIN)
AF:
0.0453
AC:
2420
AN:
53386
Middle Eastern (MID)
AF:
0.112
AC:
637
AN:
5700
European-Non Finnish (NFE)
AF:
0.0768
AC:
84687
AN:
1102320
Other (OTH)
AF:
0.0945
AC:
5666
AN:
59972
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.403
Heterozygous variant carriers
0
5358
10716
16073
21431
26789
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3264
6528
9792
13056
16320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.126
AC:
19148
AN:
151926
Hom.:
1700
Cov.:
30
AF XY:
0.125
AC XY:
9314
AN XY:
74256
show subpopulations
African (AFR)
AF:
0.245
AC:
10163
AN:
41414
American (AMR)
AF:
0.0828
AC:
1262
AN:
15236
Ashkenazi Jewish (ASJ)
AF:
0.0461
AC:
160
AN:
3472
East Asian (EAS)
AF:
0.0282
AC:
146
AN:
5170
South Asian (SAS)
AF:
0.244
AC:
1169
AN:
4794
European-Finnish (FIN)
AF:
0.0387
AC:
410
AN:
10584
Middle Eastern (MID)
AF:
0.0918
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
0.0796
AC:
5410
AN:
67950
Other (OTH)
AF:
0.123
AC:
258
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
803
1607
2410
3214
4017
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
210
420
630
840
1050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.101
Hom.:
766
Bravo
AF:
0.130
Asia WGS
AF:
0.187
AC:
651
AN:
3478
EpiCase
AF:
0.0816
EpiControl
AF:
0.0806

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
1
Insulin-resistant diabetes mellitus AND acanthosis nigricans (1)
-
-
1
Leprechaunism syndrome (1)
-
-
1
Rabson-Mendenhall syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.64
DANN
Benign
0.77
PhyloP100
-3.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00010
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2245649; hg19: chr19-7163214; COSMIC: COSV57159596; API